Annual Operating Profit
-$6.05 M
+$3.82 M+38.70%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual operating income is -$6.05 million, with the most recent change of +$3.82 million (+38.70%) on December 1, 2023.
- During the last 3 years, XRTX annual operating profit has fallen by -$5.03 million (-492.80%).
- XRTX annual operating profit is now -20394.92% below its all-time high of -$29.50 thousand, reached on February 1, 2015.
Performance
XRTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$874.70 K
+$619.00 K+41.44%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly operating income is -$874.70 thousand, with the most recent change of +$619.00 thousand (+41.44%) on September 1, 2024.
- Over the past year, XRTX quarterly operating profit has increased by +$109.00 thousand (+11.08%).
- XRTX quarterly operating profit is now -7269.67% below its all-time high of $12.20 thousand, reached on February 1, 2016.
Performance
XRTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$4.44 M
+$518.60 K+10.46%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM operating income is -$4.44 million, with the most recent change of +$518.60 thousand (+10.46%) on September 1, 2024.
- Over the past year, XRTX TTM operating profit has increased by +$1.61 million (+26.55%).
- XRTX TTM operating profit is now -75166.10% below its all-time high of -$5900.00, reached on May 1, 2014.
Performance
XRTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
XRTX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.7% | +11.1% | +26.6% |
| 3 y3 years | -492.8% | +54.1% | +52.4% |
| 5 y5 years | -611.6% | +54.1% | +52.4% |
XRTX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -111.2% | +38.7% | at high | +69.6% | -51.2% | +56.9% |
| 5 y | 5-year | -1295.3% | +38.7% | -640.6% | +69.6% | -874.3% | +56.9% |
| alltime | all time | <-9999.0% | +38.7% | -7269.7% | +69.6% | <-9999.0% | +56.9% |
XORTX Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$874.70 K(-41.4%) | -$4.44 M(-10.5%) |
| Jun 2024 | - | -$1.49 M(+37.2%) | -$4.96 M(-5.1%) |
| Mar 2024 | - | -$1.09 M(+10.7%) | -$5.23 M(-13.5%) |
| Dec 2023 | -$6.05 M(-38.7%) | -$983.70 K(-29.4%) | -$6.05 M(-21.7%) |
| Sep 2023 | - | -$1.39 M(-20.9%) | -$7.72 M(-8.4%) |
| Jun 2023 | - | -$1.76 M(-7.6%) | -$8.43 M(-9.5%) |
| Mar 2023 | - | -$1.91 M(-28.3%) | -$9.32 M(-9.4%) |
| Dec 2022 | -$9.86 M(+244.6%) | -$2.66 M(+26.5%) | -$10.29 M(+15.1%) |
| Sep 2022 | - | -$2.10 M(-20.7%) | -$8.94 M(+25.0%) |
| Jun 2022 | - | -$2.65 M(-7.8%) | -$7.16 M(+37.6%) |
| Mar 2022 | - | -$2.88 M(+119.4%) | -$5.20 M(+77.2%) |
| Dec 2021 | -$2.86 M(+180.6%) | - | - |
| Dec 2021 | - | -$1.31 M(+312.9%) | -$2.94 M(+50.0%) |
| Sep 2021 | - | -$317.40 K(-54.5%) | -$1.96 M(+1.7%) |
| Jun 2021 | - | -$698.00 K(+14.4%) | -$1.93 M(+28.4%) |
| Mar 2021 | - | -$610.40 K(+83.6%) | -$1.50 M(+48.9%) |
| Dec 2020 | -$1.02 M(+135.4%) | -$332.40 K(+16.5%) | -$1.01 M(+25.1%) |
| Sep 2020 | - | -$285.30 K(+5.0%) | -$805.30 K(+29.8%) |
| Jun 2020 | - | -$271.60 K(+130.0%) | -$620.60 K(+36.2%) |
| Mar 2020 | - | -$118.10 K(-9.4%) | -$455.80 K(-1.6%) |
| Dec 2019 | -$433.30 K | -$130.30 K(+29.5%) | -$463.10 K(+18.0%) |
| Sep 2019 | - | -$100.60 K(-5.8%) | -$392.50 K(-24.4%) |
| Jun 2019 | - | -$106.80 K(-14.8%) | -$519.40 K(-16.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$125.40 K(+110.1%) | -$623.20 K(-26.3%) |
| Dec 2018 | -$849.60 K(+130.2%) | -$59.70 K(-73.8%) | -$846.00 K(-15.9%) |
| Sep 2018 | - | -$227.50 K(+8.0%) | -$1.01 M(+11.2%) |
| Jun 2018 | - | -$210.60 K(-39.5%) | -$904.90 K(+24.0%) |
| Mar 2018 | - | -$348.20 K(+84.1%) | -$729.50 K(+57.2%) |
| Dec 2017 | -$369.00 K(+151.5%) | -$189.10 K(+512.0%) | -$464.00 K(+68.8%) |
| Nov 2017 | - | -$30.90 K(-57.3%) | -$274.90 K(-4.1%) |
| Sep 2017 | - | -$72.40 K(+34.8%) | -$286.80 K(+33.8%) |
| Aug 2017 | - | -$53.70 K(+52.6%) | -$214.40 K(+6.9%) |
| May 2017 | - | -$35.20 K(-30.2%) | -$200.50 K(+0.7%) |
| Mar 2017 | - | -$50.40 K(+56.0%) | -$199.20 K(+33.9%) |
| Feb 2017 | -$146.70 K(-51.4%) | -$32.30 K(-24.5%) | -$148.80 K(+42.7%) |
| Dec 2016 | -$301.60 K(+99.7%) | - | - |
| Nov 2016 | - | -$42.80 K(+7.5%) | -$104.30 K(-27.1%) |
| Aug 2016 | - | -$39.80 K(+17.4%) | -$143.10 K(+3.3%) |
| May 2016 | - | -$33.90 K(-377.9%) | -$138.50 K(-10.6%) |
| Feb 2016 | -$151.00 K(+411.9%) | $12.20 K(-115.0%) | -$155.00 K(-13.7%) |
| Nov 2015 | - | -$81.60 K(+131.8%) | -$179.70 K(+73.3%) |
| Aug 2015 | - | -$35.20 K(-30.2%) | -$103.70 K(+39.0%) |
| May 2015 | - | -$50.40 K(+303.2%) | -$74.60 K(+147.8%) |
| Feb 2015 | -$29.50 K | -$12.50 K(+123.2%) | -$30.10 K(+71.0%) |
| Nov 2014 | - | -$5600.00(-8.2%) | -$17.60 K(+46.7%) |
| Aug 2014 | - | -$6100.00(+3.4%) | -$12.00 K(+103.4%) |
| May 2014 | - | -$5900.00 | -$5900.00 |
FAQ
- What is XORTX Therapeutics annual operating income?
- What is the all time high annual operating profit for XORTX Therapeutics?
- What is XORTX Therapeutics annual operating profit year-on-year change?
- What is XORTX Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly operating profit year-on-year change?
- What is XORTX Therapeutics TTM operating income?
- What is the all time high TTM operating profit for XORTX Therapeutics?
- What is XORTX Therapeutics TTM operating profit year-on-year change?
What is XORTX Therapeutics annual operating income?
The current annual operating profit of XRTX is -$6.05 M
What is the all time high annual operating profit for XORTX Therapeutics?
XORTX Therapeutics all-time high annual operating income is -$29.50 K
What is XORTX Therapeutics annual operating profit year-on-year change?
Over the past year, XRTX annual operating income has changed by +$3.82 M (+38.70%)
What is XORTX Therapeutics quarterly operating income?
The current quarterly operating profit of XRTX is -$874.70 K
What is the all time high quarterly operating profit for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly operating income is $12.20 K
What is XORTX Therapeutics quarterly operating profit year-on-year change?
Over the past year, XRTX quarterly operating income has changed by +$109.00 K (+11.08%)
What is XORTX Therapeutics TTM operating income?
The current TTM operating profit of XRTX is -$4.44 M
What is the all time high TTM operating profit for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM operating income is -$5900.00
What is XORTX Therapeutics TTM operating profit year-on-year change?
Over the past year, XRTX TTM operating income has changed by +$1.61 M (+26.55%)